6 terminated. 6 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Terminated 6 |
| Phase 2 | 2 | Terminated 2 |
Follow Smoking: new trials by email Literature Review of Smoking trials Research Report on Smoking
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mindfulness Training Plus Oxytocin Effects on Smoking Behavior Oxytocin, Mindfulness, Saline Solution - Smoking, Smoking Cessation | Phase 2 / Phase 3 | Terminated | University of Southern California | 20 | 2018-10-10 | 2024-06-14 |
| Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease Metoprolol succinate, Placebo - Pulmonary Disease, Chronic Obstructive | Phase 3 | Terminated | University of Minnesota | 532 | 2016-05-01 | 2021-01-25 |
| Tailored Smoking Cessation Treatment for LIVE FOR LIFEĀ® Participants varenicline (Chantix), bupropion (Zyban), nicotine patches - Cigarette Smoking, Nicotine Dependence | Phase 2 / Phase 3 | Terminated | Duke University | 19 | 2012-05-01 | 2014-12-24 |
| Varenicline and Alcohol in Inpatient Addictions Program (IAP) Varenicline - Alcoholism, Nicotine Dependence | Phase 3 | Terminated | Mayo Clinic | 1 | 2011-01-01 | 2019-03-20 |
| Simvastatin Therapy for Moderate and Severe COPD simvastatin, Placebo - Pulmonary Disease, Chronic Obstructive | Phase 3 | Terminated | University of Minnesota | 885 | 2010-03-01 | 2018-01-02 |
| Nurse Smoking Cessation of Patients With Chronic Obstructive Pulmonary Disease (COPD) With Nicotine Replacement Therapy (NRT) and Behavioral Support nicotine sublingual tablets, low and high behavior support - Smoking, COPD | Phase 3 | Terminated | University Hospital, Gentofte, Copenhagen | 300 | 2002-02-01 | 2005-10-21 |
Pulmonary Disease, Chronic Obstructive (3) · Smoking Cessation (2) · Tobacco Use Disorder (2) · Alcoholism (1) · Body Weight (1) · Cigarette Smoking (1) · Smoking Reduction (1)
Behavior (6) · Chronic Disease (3) · Disease Attributes (3) · Lung Diseases (3) · Lung Diseases, Obstructive (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Respiratory Tract Diseases (3) · Chemically-Induced Disorders (2) · Health Behavior (2) · Mental Disorders (2) · Substance-Related Disorders (2) · Alcohol-Related Disorders (1) · Signs and Symptoms (1)
Varenicline (2) · Bupropion (1) · Metoprolol (1) · Mindfulness (1) · Oxytocin (1) · Saline Solution (1) · Simvastatin (1) · Sugars (1) · Tobacco Use Cessation Devices (1)
University of Minnesota (2) · Duke University (1) · Mayo Clinic (1) · University Hospital, Gentofte, Copenhagen (1) · University of Southern California (1)
United States (5) · Canada (1) · Denmark (1)
Mark Dransfield, MD (2) · Dennis E Niewoehner, MD (1) · Don Sin, M.D. (1) · Fernando J Martinez, MD (1) · Frank Sciurba, MD (1) · George Washko, MD (1) · Gerard J Criner, MD (1) · Jed E Rose, Ph.D. (1) · John Connett, PhD (1) · John E Connett, PhD (1) · Mark Frye, MD (1) · Matthew Kirkpatrick, PhD (1) · Richard Casaburi, MD, PhD (1) · Richard K Albert, MD (1)
PMID 24836125, PMID 27267111, PMID 29065885, PMID 29444682, PMID 31633896, PMID 33638931, PMID 34229290, PMID 35363600
U10HL074424 (1)